Thank You for Contacting INNOV Research

Your message has been received. A member of our team will review your inquiry and follow up with you shortly—typically within one business day.

If you reached out about a custom antibody request or product inquiry, we may contact you for additional details to ensure we can support your research accurately.

In the meantime, you can:

Need something urgent? Call us directly at (248) 896-0145.

We’re proud to support your research and look forward to assisting you.

Your source for all 
things biotech

Stay informed with our expert insights, industry news, and groundbreaking discoveries.

News

GlaxoSmithKline, Emergent BioSolutions test Ebola vaccines

According to FierceBiotech's March 18 article, GlaxoSmithKline (GSK) is testing out an Ebola vaccine in Africa. It is interested to...

Innovative Research Product References-February Publications
Innovative Research Product References-February Publications
News

Innovative Research Product References-February Publications

(February 2, 2015) Innovative Research's Human Cortisone Chemiluminescent CLIA Kit was recently used in the following study: Inhibition of 11-HSD2...

Innovative Research Product References-January Publications
Innovative Research Product References-January Publications
News

Innovative Research Product References-January Publications

(January 6, 2015) Innovative Research's Human Neutrophil Elastase was recently used in the following study: Synthesis and biological evaluation of...

Innovative Research Product References-December Publications
Innovative Research Product References-December Publications
News

Innovative Research Product References-December Publications

(December 5, 2014) Innovative Research's Single Donor Human Whole Blood was recently used in the following study: The Nrf2 activator...

Bispecific Antibodies: New and Improved Anticancer Weapons?
Bispecific Antibodies: New and Improved Anticancer Weapons?
News

Bispecific Antibodies: New and Improved Anticancer Weapons?

While monoclonal antibodies are widely used for therapeutically and commercially, recent developments show that bispecific antibodies (bsAbs), or dual specificity...